Ligand's business is focused on developing programs that lead to licensing deals or acquiring royalty revenue-generating assets and coupling them to an efficient, lean corporate cost structure. Ligand's goal is to produce a bottom line that generates sustainable profits and positive cash-flow. By diversifying the portfolio of assets across numerous technology types, therapeutic areas, drug targets, and industry partners, we offer investors a de-risked opportunity to invest in the complex and unpredictable pharmaceutical industry.

11119 N Torrey Pines Rd La Jolla, CA 92037
Tel: 913-685-8856, 858-550-7500